BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawamura K, Fukumura S, Nikaido K, Tachi N, Kozuka N, Seino T, Hatakeyama K, Mori M, Ito YM, Takami A, Hinotsu S, Kuno A, Kawasaki Y, Horio Y, Tsutsumi H. Resveratrol improves motor function in patients with muscular dystrophies: an open-label, single-arm, phase IIa study. Sci Rep 2020;10:20585. [PMID: 33239684 DOI: 10.1038/s41598-020-77197-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 González-Jamett A, Vásquez W, Cifuentes-Riveros G, Martínez-Pando R, Sáez JC, Cárdenas AM. Oxidative Stress, Inflammation and Connexin Hemichannels in Muscular Dystrophies. Biomedicines 2022;10:507. [PMID: 35203715 DOI: 10.3390/biomedicines10020507] [Reference Citation Analysis]
2 Garegnani L, Hyland M, Roson Rodriguez P, Escobar Liquitay CME, Franco JV. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. Cochrane Database Syst Rev 2021;11:CD013720. [PMID: 34748221 DOI: 10.1002/14651858.CD013720.pub2] [Reference Citation Analysis]
3 Lee I. Regulation of Cytochrome c Oxidase by Natural Compounds Resveratrol, (-)-Epicatechin, and Betaine. Cells 2021;10:1346. [PMID: 34072396 DOI: 10.3390/cells10061346] [Reference Citation Analysis]
4 Woodman KG, Coles CA, Lamandé SR, White JD. Resveratrol Promotes Hypertrophy in Wildtype Skeletal Muscle and Reduces Muscle Necrosis and Gene Expression of Inflammatory Markers in Mdx Mice. Molecules 2021;26:853. [PMID: 33561994 DOI: 10.3390/molecules26040853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Hosoda R, Hamada H, Uesugi D, Iwahara N, Nojima I, Horio Y, Kuno A. Different Antioxidative and Antiapoptotic Effects of Piceatannol and Resveratrol. J Pharmacol Exp Ther 2021;376:385-96. [PMID: 33335015 DOI: 10.1124/jpet.120.000096] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Ohlendieck K, Swandulla D. Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy. Pflugers Arch 2021;473:1813-39. [PMID: 34553265 DOI: 10.1007/s00424-021-02623-1] [Reference Citation Analysis]
7 Garegnani L, Hyland M, Roson Rodriguez P, Escobar Liquitay CM, Franco JV. Antioxidants to prevent respiratory decline in people with Duchenne muscular dystrophy and progressive respiratory decline. Cochrane Database Syst Rev 2021;12:CD013720. [PMID: 34850383 DOI: 10.1002/14651858.CD013720.pub3] [Reference Citation Analysis]
8 Chaytow H, Faller KME, Huang YT, Gillingwater TH. Spinal muscular atrophy: From approved therapies to future therapeutic targets for personalized medicine. Cell Rep Med 2021;2:100346. [PMID: 34337562 DOI: 10.1016/j.xcrm.2021.100346] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]